COVID-19 & ACE-inhibitors or ARBs

NICE has published COVID-19 rapid evidence summary: angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) in people with or at risk of COVID-19 – which includes the following conclusion: Despite biological plausibility for the role of ACEIs and ARBs in both increasing and decreasing the risk of COVID-19 and its complications, this evidence review has not found any Continue Reading »

COVID-19 & NSAIDs – NICE Advice

NICE has published a COVID-19 rapid evidence summary on Long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19 – which includes the following conclusion: No evidence was found to suggest that people taking NSAIDs for a long-term condition should be advised to stop treatment in the context of COVID‑19. Stopping or switching NSAID treatment Continue Reading »

Medicines Matters – COVID-19 Special Bulletin 3

Medicine Matters – COVID-19 Bulletin 3 The NECS Medicines Optimisation Care Home & Social Care Support Team have produced a series of COVID-19 Special Bulletins to help Care Staff respond and adjust to the challenges and changes arising from the COVID-19 pandemic. The third Special Bulletin Includes: Communication covering effective handover and delegating medicine related tasks Digital technology, new Continue Reading »